Breynaert Annelies, Bosscher Douwina, Kahnt Ariane, Claeys Magda, Cos Paul, Pieters Luc, Hermans Nina
NatuRA - Laboratory of Nutrition and Functional Food Science, Department of Pharmaceutical Sciences, University of Antwerp, Belgium.
Laboratory of Bio-Organic Mass Spectrometry, Department of Pharmaceutical Sciences, University of Antwerp, Belgium.
Planta Med. 2015 Aug;81(12-13):1075-83. doi: 10.1055/s-0035-1546154. Epub 2015 Jul 10.
The biological effects of polyphenols depend on their mechanism of action in the body. This is affected by bioconversion by colon microbiota and absorption of colonic metabolites. We developed and validated an in vitro continuous flow dialysis model with colon phase (GastroIntestinal dialysis model with colon phase) to study the gastrointestinal metabolism and absorption of phenolic food constituents. Chlorogenic acid was used as model compound. The physiological conditions during gastrointestinal digestion were mimicked. A continuous flow dialysis system simulated the one-way absorption by passive diffusion from lumen to mucosa. The colon phase was developed using pooled faecal suspensions. Several methodological aspects including implementation of an anaerobic environment, adapted Wilkins Chalgren broth medium, 1.10(8) CFU/mL bacteria suspension as inoculum, pH adaptation to 5.8 and implementation of the dialysis system were conducted. Validation of the GastroIntestinal dialysis model with colon phase system showed a good recovery and precision (CV < 16 %). Availability of chlorogenic acid in the small intestinal phase (37 ± 3 %) of the GastroIntestinal dialysis model with colon phase is comparable with in vivo studies on ileostomy patients. In the colon phase, the human faecal microbiota deconjugated chlorogenic acid to caffeic acid, 3,4-dihydroxyphenyl propionic acid, 4-hydroxybenzoic acid, 3- or 4-hydroxyphenyl acetic acid, 2-methoxy-4-methylphenol and 3-phenylpropionic acid. The GastroIntestinal dialysis model with colon phase is a new, reliable gastrointestinal simulation system. It permits a fast and easy way to predict the availability of complex secondary metabolites, and to detect metabolites in an early stage after digestion. Isolation and identification of these metabolites may be used as references for in vivo bioavailability experiments and for investigating their bioactivity in in vitro experiments.
多酚的生物学效应取决于其在体内的作用机制。这会受到结肠微生物群的生物转化以及结肠代谢产物吸收的影响。我们开发并验证了一种具有结肠阶段的体外连续流动透析模型(带结肠阶段的胃肠透析模型),以研究酚类食物成分的胃肠代谢和吸收。绿原酸用作模型化合物。模拟了胃肠消化过程中的生理条件。连续流动透析系统模拟了从肠腔到黏膜的被动扩散单向吸收。使用混合粪便悬液构建结肠阶段。进行了几个方法学方面的操作,包括实施厌氧环境、采用改良的威尔金斯·查尔格伦肉汤培养基、接种1.10(8) CFU/mL细菌悬液、将pH值调节至5.8以及实施透析系统。带结肠阶段的胃肠透析模型系统的验证显示出良好的回收率和精密度(CV < 16%)。带结肠阶段的胃肠透析模型在小肠阶段绿原酸的可利用性(37 ± 3%)与对回肠造口术患者的体内研究相当。在结肠阶段,人粪便微生物群将绿原酸去共轭生成咖啡酸、3,4 - 二羟基苯丙酸、4 - 羟基苯甲酸、3 - 或4 - 羟基苯乙酸、2 - 甲氧基 - 4 - 甲基苯酚和3 - 苯丙酸。带结肠阶段的胃肠透析模型是一种新型、可靠的胃肠模拟系统。它提供了一种快速简便的方法来预测复杂次生代谢产物的可利用性,并在消化后的早期阶段检测代谢产物。这些代谢产物的分离和鉴定可作为体内生物利用度实验的参考以及用于在体外实验中研究它们的生物活性。